Showing results (141-150 of 196) with videos related to
Sort By:
Pageof 20
The Lancet. Respiratory Medicine|March 26, 2026
Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort studyKiran Reddy, Pratik Sinha, David B Antcliffe, et al.The Journal of Infectious Diseases|May 25, 2021
Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 InfectionJeremy Ratcliff, Dung Nguyen, Matthew Fish, et al.The Lancet. Respiratory Medicine|December 24, 2023
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicineSara Cajander, Matthijs Kox, Brendon P Scicluna, et al.The Lancet. Respiratory Medicine|February 26, 2024
Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapiesManu Shankar-Hari, Thierry Calandra, Miguel P Soares, et al.Nature Reviews. Nephrology|September 24, 2025
The immunology of sepsis: translating new insights into clinical practiceMatthijs Kox, Michael Bauer, Lieuwe D J Bos, et al.Biorxiv : the Preprint Server for Biology|February 10, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Jeffrey Seow, Isabella Huettner, et al.Journal of Clinical Microbiology|March 24, 2022
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCRJeremy Ratcliff, Farah Al-Beidh, Sagida Bibi, et al.The Lancet. Infectious Diseases|October 22, 2019
Current gaps in sepsis immunology: new opportunities for translational researchIgnacio Rubio, Marcin F Osuchowski, Manu Shankar-Hari, et al.Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.American Journal of Respiratory and Critical Care Medicine|May 8, 2023
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical TrialEllen A Gorman, Jennifer Rynne, Hannah J Gardiner, et al.Pageof 20